Thermo fisher scientific showcases enhanced accelerator™ drug development capabilities and openai strategic collaboration at cphi frankfurt 2025

Frankfurt, germany--(business wire)--thermo fisher scientific inc., the world leader in serving science, will showcase its latest flexible solutions to help boost efficiency and scale in biopharmaceutical manufacturing at every stage of drug development during cphi frankfurt 2025 (october 28–30, booth #5.1a8, hall 5.1). leaders from across the organization will participate in a series of panel discussions highlighting industry trends, sustainability strategies and how collaboration can accelera.
TMO Ratings Summary
TMO Quant Ranking